Data di Pubblicazione:
2006
Abstract:
Amyloid-b peptide (Ab) is a 39-43 amino acid peptide
strongly involved in the development of Alzheimers disease.
In the plasma, the major form is AbACHTUNGTRENUNG(1-40), which aggregates
to form neuritic plaques and neurofibrillary tangles in the
diseased brain.[1] Special attention has been paid to the role of
methionine residue 35 (Met35), which has been shown to play
a critical role in the oxidative-stress and neurotoxicity
properties exhibited by Ab. This was demonstrated by
replacing Met35 with other amino acids.[2, 3] The molecular
basis of this stress involves oxidation to the methionine
radical cation and subsequent formation of methionine
sulfoxide and/or electron transfer to other residues.[4, 5] However,
a clear picture of the chemical degradation paths and
their influence on the disease aetiology is far from being
achieved.
In the context of free-radical damage, the concept of
reductive stress has received much less attention than that of
oxidative stress.[6] The reductive attack of HC atoms on
methionine is known to cause degradation, with formation
of a-aminobutyric acid and CH3SH.[7] The sulfur-centered
radical intermediates involved in such degradation have been
recently connected with a type of tandem protein-lipid
damage, based on the reaction of thiyl radicals with unsaturated
fatty acids.[8] We were interested in applying a chemical
biology approach to focus on radical damage of Ab, by
replacement of Met35 with a-aminobutyric acid in the
peptide sequence. The replacement of methionine by other
amino acids inAb is known to occur by genetic mutation, as in
the case of valine, which causes the disease to appear at very
early ages.[9] In this paper we describe the reaction ofHC atoms
with the 40-residueAbACHTUNGTRENUNG(1-40) or its reversed sequenceAbACHTUNGTRENUNG(40-
1), the detection of tandem protein-lipid damage, and the
isolation and identification of the peptide modified at the
Met35 residue.
To begin with, the reaction of HC atoms with the
methionine moiety was monitored by using trans-lipids as
markers.[8, 10] Liposomes were prepared from 1-palmitoyl-2-
oleoyl phosphatidylcholine (POPC), in the form of large
unilamellar vesicles (LUVETs) with a 100 nm diameter; these
vesicles were obtained by membrane extrusion with LiposoFast.[
10, 11] AbACHTUNGTRENUNG(1-40) or AbACHTUNGTRENUNG(40-1) was added to this
suspension. A small amount of tert-butanol (0.20m), which
did not exceed 1% of the total volume, was also added. The
oleate (cis-9-octadecenoic acid) content of POPC was kept at
8.7 mm, whereas three peptide concentrations (150, 300,
450 mm), corresponding to lipid/peptide ratios of 58:1, 58:2,
and 58:3, respectively, were used. In at least two of these
conditions (58:1 and 58:2 ratios), the membrane association
of the peptide could be neglected, according to recent data.[12]
The mixtures were saturated with N2Oprior to g irradiation at
a dose rate of 12.0 Gymin1. After irradiation, lipid isolation,
and derivatization to the corresponding fatty acid methyl
esters,[13] GC analysis was used to determine the cis/trans
ratio.[11]
Tipologia CRIS:
01.01 Articolo in rivista
Elenco autori:
Ferreri, Carla; Chatgilialoglu, Chryssostomos
Link alla scheda completa:
Pubblicato in: